idiopathic pulmonary fibrosis
Respiratory · 2015–2024
8decisions
2medicines
7carried consumer input
185individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| nintedanib Idiopathic Pulmonary Fibrosis (IPF) and Chronic Fibrosing Interstitial Lung Disease with a progressive phenotype (PF-ILD). | Nov 2024 | Not recommended | input received |
| pirfenidone Treatment of idiopathic pulmonary fibrosis (IPF). This submission was for new tablet forms (267 mg and 801 mg) as formulation changes to the previously listed… | Mar 2018 | Recommended with restriction | none received |
| pirfenidone Idiopathic pulmonary fibrosis (IPF) in patients aged 40 years or older with confirmed diagnosis, FVC ≥50% predicted, and DLCO ≥30% predicted. | Mar 2016 | Not recommended | 1 individuals |
| nintedanib Treatment of patients with idiopathic pulmonary fibrosis (IPF), specifically mild to moderate IPF. | Nov 2016 | Recommended | 33 individuals |
| pirfenidone Treatment of idiopathic pulmonary fibrosis (IPF) in patients with confirmed diagnosis, FVC ≥50% predicted, and DLCO ≥30% predicted, aged 40 years or older. | Nov 2016 | Deferred | 50 individuals |
| nintedanib Treatment of idiopathic pulmonary fibrosis (IPF) in adult patients aged 40 years and over with mild to moderate disease. | Mar 2015 | Not recommended | 3 individuals |
| nintedanib Treatment of idiopathic pulmonary fibrosis (IPF), specifically mild to moderate IPF in patients aged 40 years or older with confirmed diagnosis and adequate… | Nov 2015 | Deferred | 50 individuals |
| pirfenidone Treatment of idiopathic pulmonary fibrosis (IPF) in patients with confirmed diagnosis, HRCT findings consistent with IPF, FVC ≥50% predicted, and DLCO ≥30%… | Nov 2015 | Recommended with restriction | 48 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 7 of 8 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.